MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 64 filers reported holding MARKER THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $28,938 | -27.7% | 108,830 | 0.0% | 0.00% | – |
Q3 2022 | $40,000 | +11.1% | 108,830 | 0.0% | 0.00% | – |
Q2 2022 | $36,000 | -25.0% | 108,830 | 0.0% | 0.00% | – |
Q1 2022 | $48,000 | -53.4% | 108,830 | 0.0% | 0.00% | – |
Q4 2021 | $103,000 | -44.0% | 108,830 | 0.0% | 0.00% | – |
Q3 2021 | $184,000 | -42.5% | 108,830 | -5.1% | 0.00% | – |
Q2 2021 | $320,000 | -57.3% | 114,693 | -65.8% | 0.00% | – |
Q1 2021 | $750,000 | +48.2% | 335,058 | -4.0% | 0.00% | – |
Q4 2020 | $506,000 | -1.4% | 348,982 | +2.1% | 0.00% | – |
Q3 2020 | $513,000 | -33.0% | 341,733 | -7.6% | 0.00% | – |
Q2 2020 | $766,000 | +18.4% | 369,889 | +8.7% | 0.00% | – |
Q1 2020 | $647,000 | -31.8% | 340,221 | +3.3% | 0.00% | – |
Q4 2019 | $948,000 | -43.5% | 329,248 | +0.3% | 0.00% | – |
Q3 2019 | $1,678,000 | +71.9% | 328,388 | +166.5% | 0.00% | – |
Q2 2019 | $976,000 | +170.4% | 123,217 | +125.0% | 0.00% | – |
Q1 2019 | $361,000 | +16.8% | 54,766 | -1.7% | 0.00% | – |
Q4 2018 | $309,000 | – | 55,718 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 2,000,000 | $10,220,000 | 5.33% |
NEA Management Company, LLC | 5,000,000 | $25,550,000 | 2.12% |
One68 Global Capital, LLC | 30,000 | $153,000 | 0.35% |
Perceptive Advisors | 2,000,000 | $10,220,000 | 0.28% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 100,000 | $511,000 | 0.18% |
Quad Capital Management Advisors LLC | 58,232 | $298,000 | 0.15% |
Riggs Asset Managment Co. Inc. | 46,019 | $235,000 | 0.12% |
Baker Brothers Advisors | 1,500,000 | $7,665,000 | 0.05% |
FNY Investment Advisers, LLC | 32,058 | $163,000 | 0.05% |
WEDBUSH SECURITIES INC | 56,568 | $289,000 | 0.03% |